Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Homecare Homebase (HCHB) unveiled Curate: Scribe, an AI‑assisted documentation tool built into its EHR. Developed with StenoHealth, the feature generates draft clinical notes that clinicians can review and edit, aiming to cut the time spent on paperwork. By embedding AI directly in the existing visit workflow, HCHB seeks to eliminate app‑hopping and improve compliance for home health and hospice agencies. A pilot rollout is scheduled for the first half of 2026.
Ethermed and VisiQuate announced a strategic partnership that merges Ethermed’s embedded prior‑authorization automation with VisiQuate’s AI‑driven predictive models, data engine, and robotic process automation. The combined platform predicts authorization requirements, executes submissions directly within clinical workflows, and continuously refines its...
Women’s health funding has exploded, with investment rising over 300% since 2018 and tripling again by 2024, reflecting a clear market opportunity. Yet commercialization lags, leaving startups unable to scale, patients facing delayed access, and revenue potential unrealized. Fragmented care...
Researchers at the Cleveland Clinic pursued fragment‑based inhibitors of SARS‑CoV‑2 NSP14, a viral exonuclease essential for replication and immune evasion. Initial crystal‑guided merges appeared active in a biochemical assay, prompting optimism about fragment linking. Subsequent resynthesis and rigorous purification revealed...
The Bureau of Labor Statistics reported that total non‑farm payrolls fell by 92,000 jobs in February, with health‑care employment shrinking by 28,000 jobs after a wave of worker strikes. Despite the dip, the health‑care sector has added an average of...
Natera announced two peer‑reviewed studies demonstrating the clinical utility of its personalized ctDNA assay, Signatera, in anal squamous cell carcinoma and locally advanced rectal cancer. In the ASCC cohort of 84 patients, baseline negativity or clearance of ctDNA during chemoradiotherapy...
Elevara Medicines has dosed the first patient in its phase 2b START‑SYNERGY trial, testing the oral CDK4/6 inhibitor ELV001 in rheumatoid arthritis patients who have failed methotrexate and TNF inhibitors. The randomized, placebo‑controlled study will enroll about 180 participants across nine...
Researchers at the University of Illinois Urbana‑Champaign have engineered a photonic‑nanomaterial platform that senses microRNA and DNA signatures linked to cancer up to five to eight years before conventional diagnostics can. The system leverages photonic crystal grating resonance and nano‑assemblies...
A multicenter retrospective cohort of nearly 15,000 low‑risk adults showed that 80% of patients with Lipoprotein(a) above 50 mg/dL did not start any lipid‑lowering medication within 90 days of testing. Initiation of statins was modest, while use of PCSK9 inhibitors and...
Cir‑Code Bio‑med, a Chinese biotech focused on circular RNA medicines, has secured an Investigational New Drug (IND) approval from the U.S. Food and Drug Administration to commence its first human trial. The therapy targets a rare genetic disorder using a...
It’s incredibly hard to see through the current AI hype in healthcare. To facilitate that, I have mapped the rapidly expanding universe of AI use cases in healthcare from early-stage “on the horizon” innovations to “safe bets” that are already backed...
Physicians are adopting minimally invasive tools like radiofrequency ablation (RFA) to treat benign thyroid nodules, reducing the need for surgery and preserving gland function. Enhanced diagnostics—including high‑resolution ultrasound and comprehensive hormone panels—are improving accuracy and enabling data‑driven treatment adjustments. Integrating...
Oxford Medical Simulation (OMS) has secured €5.78 million in growth funding from Salica Investments. The capital will fund OMS’s expansion into U.S. health systems and universities, and accelerate product innovation such as AI‑driven scenarios, learning analytics, and workflow tools. The round...
Circle Health Group’s Clementine Churchill Hospital in London has become the UK’s first private facility to install Intuitive’s da Vinci 5 surgical system. The fifth‑generation robot, featuring AI analytics and ten‑thousand‑fold computing power, supports minimally invasive procedures in general surgery,...
In 2021 CMS mandated hospitals to publish machine‑readable price lists for 300 common services, hoping transparent pricing would spur competition and lower costs. Five years later, health spending still outpaces inflation and the rule’s impact remains minimal. Low public awareness,...
Bayer’s 2018 acquisition of Monsanto brought a wave of glyphosate lawsuits, prompting a proposed $7.25 billion class settlement and an undisclosed additional pact. The company’s CEO, Bill Anderson, is steering a restructuring that includes 12,000 layoffs and a focus on pharma...
The Professional Standards Authority has announced it will support the General Medical Council’s appeal of the Medical Practitioners Tribunal Service’s decision that cleared Dr Ghassan Abu‑Sitta of terrorism‑related misconduct. The appeal follows a petition signed by thousands of doctors demanding the...
Structure Therapeutics announced that its daily oral GLP‑1 obesity pill produced an average 16% body‑weight reduction versus placebo after 44 weeks in a Phase 2 trial. The result outperforms Eli Lilly’s orforglipron, which showed about 11% loss over 72 weeks, and rivals...
The irony I find myself returning to is that MRI technology has not made us better diagnosticians. It has, in many cases, made us worse ones, because the image is so concrete and the language of the report so authoritative...
Havas Life London’s new report reveals that stigma is a pervasive, structural barrier in rare disease care, affecting 89% of patients and caregivers surveyed. Healthcare settings account for the largest share of stigma incidents, with 42% reporting dismissed symptoms and...
Structure Therapeutics released Phase 2 data for its oral GLP‑1 agonist, positioning the candidate as a next‑generation alternative to injectable therapies from Eli Lilly and Novo Nordisk. The trial demonstrated a mean 30% reduction in HbA1c and 70% of participants achieving target...
The Atlantic outlines a surge in off‑label and experimental peptide use, noting that Vyleesi—approved for women’s hypoactive sexual desire disorder—is being bought by men through “research use only” listings and online pharmacies. Compounding pharmacies and telehealth firms now market customized...
The American College of Radiology’s 2025 Intersociety Meeting produced ten actionable solutions to halt the erosion of academic radiology’s core mission of patient care, education, and research. Experts cite practice consolidation, rising imaging volumes and burnout as primary threats. Recommendations...
The FDA is accelerating the shift of prescription medicines to over‑the‑counter status, highlighted by Commissioner Marty Makary’s call for broader OTC availability and the introduction of the Additional Condition for Non‑Prescription Use (ACNU) framework. Former FDA counsel Heidi Gertner stresses...
The AIDS Healthcare Foundation (AHF) Europe will stage an advocacy action and press conference in Brussels on March 18, 2026, urging the European Commission to adopt a legally binding Pathogen Access and Benefit‑Sharing (PABS) Annex to the WHO Pandemic Agreement. The organization...
A new qualitative study in BMC Geriatrics reveals the intense psychological, physical, and social pressures faced by family caregivers of late‑stage dementia patients. Interviews expose high rates of depression, anxiety, and burnout, compounded by fragmented health‑care navigation and dwindling social...
The blog recaps the 2026 New Antibacterial Discovery and Development conference in Tuscany, where researchers presented emerging strategies against antimicrobial resistance (AMR). Dr. Quave highlighted her lab’s plant‑derived natural products targeting Gardnerella vaginalis, a key cause of bacterial vaginosis. The...
Mike Schultz retired from Paralympic snowboarding after winning a bronze in the Cortina banked slalom, capping a career that includes four medals and two golds. He is celebrated for designing the BioDapt prosthetic knee and foot that now equip every...
Santa Cruz‑based Unnatural Products secured a $45 million Series B round to accelerate its macrocycle drug platform. The financing follows a newly announced partnership with Novartis that will grant the pharma giant early access to the company’s pipeline and a co‑development option...
Internal HHS memos released in a lawsuit reveal officials ignored about 99% of available safety and efficacy data when deciding to end COVID‑19 vaccine recommendations for pregnant people and children. The decision was announced by HHS Secretary Robert F. Kennedy...
RevnaBio received triple accreditation from the American Association for Laboratory Accreditation (A2LA) for ISO 15189, ISO 20387 and ISO/IEC 17043, validating its medical laboratory, biobanking and proficiency‑testing operations. The certifications boost diagnostic quality, enable local molecular testing, and provide a trusted platform for...
Tongji Hospital in Wuhan apologized after a patient was left inside an MRI scanner for nearly six hours due to a failed shift‑handover. The attending physician marked the exam complete at 12:10 a.m., but the patient remained immobile until cleaning staff...
India’s medical‑device market now requires every imported device to secure a CDSCO import licence through the SUGAM portal, regardless of risk class. Manufacturers must first classify the product under the 2017 Medical Device Rules, appoint an Indian Authorized Agent, and...
Bayer disclosed results from the pivotal Phase III FIND‑CKD trial evaluating Kerendia (finerenone) in more than 1,500 adults with non‑diabetic chronic kidney disease. Patients received 10 mg or 20 mg of Kerendia alongside standard of care and were compared with placebo. The study...
Still managing your clinic with paper files and manual registers? Upgrade to Medler HMS and simplify your practice. ✔ Patient Management ✔ Smart Appointments ✔ Digital Prescriptions ✔ Lab & Inventory ✔ Billing & Payments ✔ Automated Follow-ups ✔ Analytics Dashboard 🚀 Start your 45 Days Free Trial 📞 +91-9289363999 🌐...
Pretty impressive data from $gpcr, which remains my favorite ticker. Structure's obesity pill shows weight loss promise in Phase 2 trial https://t.co/T0JU2UuftY
The 31st Annual Executive War College will convene April 28‑29 in New Orleans, spotlighting early‑adopter labs tackling reimbursement pressure, workforce shortages, and new regulations. Speakers include MD Anderson’s Walter McAndrew on molecular workflow cost cuts, Abbott’s Jonathan Burgart on turning excess capacity...
Federal officials have reassigned two senior employees of the World Trade Center Health Program to Immigration and Customs Enforcement and the Indian Health Service, deepening an already severe staffing shortage. The program, budgeted for 120 workers, now operates with only...
KORU Medical has obtained European Union Medical Devices Regulation (EU MDR) certification for its Freedom60 infusion pump, which includes an adapter for 50 ml prefilled syringes, allowing commercialisation across the EU. The pump complements the FreedomEDGE system that supports 20 ml cartridges,...
Johnson & Johnson announced encouraging Phase I data for its intravesical drug‑releasing system Erda‑iDRS in non‑muscle‑invasive bladder cancer (NMIBC) with FGFR alterations. The trial met its primary safety endpoint and delivered an 89% complete response rate in intermediate‑risk patients, with responses...
A Spanish study of 440 MS patients and 241 matched controls found restless legs syndrome (RLS) twice as common in MS. Confirmed RLS prevalence was 15.2% among MS patients versus 7.9% in controls. Pyramidal symptoms and family history raised RLS...
Kistler Group and ATS Life Sciences Systems have launched the Symphoni platform, a high‑speed medical device assembly line capable of processing up to 320 parts per minute while cutting tooling requirements by 90 percent. The system combines Kistler’s force and displacement...
The article examines how blast and crush injuries in Gaza, Lebanon, and Iran are compounded by the collapse of medical infrastructure during urban kinetic warfare. It argues that survival rates drop not solely because of injury severity but due to...
Liverpool‑based Spotlight Pathology has closed a £1.4 million seed round to accelerate its AI‑driven blood cancer diagnostic platform. The round was co‑led by the UK Innovation and Science Seed Fund and the Liverpool City Region Seed Fund, earmarked for product development,...
Asian language speakers with limited English proficiency face major barriers to mental‑health care in the United States. A new cross‑sectional study of 3,847 facilities from 2015‑2024 found that only 5.6 % offered services in an Asian language in 2024, down from...
Healthcare leaders at HIMSS 2026 highlighted how moving Epic to AWS has become a mainstream strategy, now adopted by over 50 systems across North America and Australia. The cloud foundation enabled Jupiter Medical Center to slash radiology‑scheduling backlogs by 60% and...
Regulatory scrutiny and soaring drug prices are forcing pharmacy benefit managers (PBMs) to deliver real‑time data to their clients. Traditional reporting cycles of 30‑90 days leave payers reacting to problems after they occur, eroding trust and increasing churn risk. RxSense...
During the Medicare Advantage open enrollment period, beneficiaries can switch to Original Medicare, but obtaining a Medigap supplement may be blocked by medical underwriting. While federal law offers a six‑month guaranteed‑issue window for new Medicare Part B enrollees, most retirees lose...
Eric Dickson transformed UMass Memorial Health from a $10 million‑a‑month loss and junk‑bond rating into a high‑performing system by building a Lean‑based management framework. Over 12 years, the system evolved through 18 versions, standardizing ten core processes and empowering 13,000 staff...
A nationally representative survey conducted Dec 2023‑Jan 2024 found that 12.1% of U.S. adults have ever used psilocybin, and 26.5% of those users microdosed on their last occasion. Among the 3.1% who used psilocybin in the past year, nearly half (46.9%) reported...
